期刊文献+

降钙素原指导脓毒血症患者抗感染治疗的研究 被引量:13

Procalcitonin Guidance in Patients with Sepsis and Anti-infective Treatment
下载PDF
导出
摘要 目的观察降钙素原(PCT)指导ICU中的脓毒血症患者的抗生素治疗是否能减少抗生素的使用。方法选择符合脓毒血症诊断标准的患者51例,前瞻、随机分为PCT指导治疗组(24例)和标准治疗组(27例)。分别使用PCT指导抗生素使用和标准治疗。记录病人住ICU天数、抗生素使用天数、抗生素相关副作用。结果降钙素原指导治疗组抗生素使用时间同标准治疗组比较明显减少(8.9±2.4[n=24]vs 12.4±2.8[n=27]d,P<0.05);抗生素相关副作用的发生PCT组均较对照组明显改善(21.1%[n=24],vs 29.8%[n=27],P<0.05);两组患者ICU住院天数没有显著差异(9.7±2.6[n=24]vs 10.5±2.7[n=27]d,,P>0.05)。结论降钙素原指导脓毒血症患者的抗感染治疗可以减少抗生素的疗程及副作用。 Objective To observe whether using a PCT algorithm can reduce antibiotic exposure.Methods 51 patients to comply with the diagnostic criterion of sepsis were randomized to administration of antibiotics based on a PCT algorithm with predefined cutoff ranges for initiating or stopping antibiotics(PCT group [n=24]) or according to standard guidelines(control group [n=27]).The length of patient stay in ICU,duration and adverse effects of antibiotics were recorded.Results The mean duration of antibiotics exposure in the PCT vs control groups was lower in PCT group(8.9±2.4 [n=24] vs 12.4 ±2.8 [n=27] days,P0.05).Antibiotic-associated adverse were less frequent in the PCT group(21.1% [n=24],vs 29.8% [n=27],P 0.05).The length of two groups patient stay in ICU was similar(9.7±2.6 [n=24] vs 10.5±2.7 [n=27]days,P0.05).Conclusion In patients with sepsis,a strategy of PCT guidance compared with standard guidelines resulted in lower antibiotic exposure,as well as lower rates of and antibiotic-associated adverse effects.
出处 《中国医药指南》 2012年第9期19-20,共2页 Guide of China Medicine
关键词 降钙素原 脓毒血症 PCT Procalcitonin Sepsis
  • 相关文献

参考文献10

  • 1Linde-Zwirble WT,Angus DC. Severe sepsis epidemiology:sampling,selection,and society[J].Critical Care,2004,(04):222-226.doi:10.1186/cc2917.
  • 2Angus DC,Linde-Zwirble WT,Lidicker J. Epidemiology of severe sepsis in the United States:analysis of incidence,outcome,and associated costs of care[J].Critical Care Medicine,2001,(07):1303-1310.doi:10.1097/00003246-200107000-00002.
  • 3Vincent JL,Sakr Y,Sprung CL. Sepsis Occurrence in Acutely Ill Patients Investigators.Sepsis in European intensive care units:results of the SOAP study[J].Critical Care Medicine,2006,(02):344-353.doi:10.1097/01.CCM.0000194725.48928.3A.
  • 4Levy MM,Fink MP,Marshall JC. 2001 SCCM/ESICM/ACCP/ ATS/SIS international sepsis definitions conference[J].Critical Care Medicine,2003,(04):1250-1256.
  • 5Levy MM,Dellinger RP,Townsend SR. The Surviving Sepsis Campaign:results of an international guideline-based performance improvement program targeting severe sepsis[J].Critical Care Medicine,2010,(02):368.doi:10.1097/CCM.0b013e3181cb0cdc.
  • 6Muller B,White JC,Nylen ES. Ubiquitous expression of the calcitonin-I gene in multiple tissues in response to sepsis[J].Journal of Clinical Endocrinology and Metabolism,2001,(01):396-404.
  • 7Gogos CA,Drosou E,Bassaris HP. Pro-versus anti-inflammatory cytokine profile in patients with severe sepsis:a marker for prognosis and future therapeutic options[J].Journal of Infectious Diseases,2000,(01):176-180.doi:10.1086/315214.
  • 8Christ-Crain M,Muller B. Procalcitonin in bacterial infections-hype,hope,more or less[J].Swiss Med,2005,(31/32):451-460.
  • 9Christ-Crain M,Muller B. Biomarkers in respiratory tract infections:diagnostic guides to antibiotic prescription,prognostic markers and mediators[J].European Respiratory Journal,2007,(03):556-573.doi:10.1183/09031936.00166106.
  • 10Linscheid P,Seboek D,Zulewski H. Autocrine/paracrine role of inflammation-mediated calcitonin gene-related peptide and adrenomedullin expression in human adipose tissue[J].Endocrinol ogy,2005,(06):2699-2708.

同被引文献109

引证文献13

二级引证文献57

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部